Inventor · disambiguated record
James F. Oliviero, Iii
Also filed as: OLIVIERO III JAMES F · OLIVIERO JAMES F
0 granted patents·8 pending applications·0 citations·filing 2013–2024
Files withKERYX BIOPHARMACEUTICALS INC8
Top patents by PatentIndex Score
8 records- 0159US2025360167A1Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0244US2014234416A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0341US2013345303A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0440US2024041816A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0535US2016256486A1Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0635US2015079168A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0734US2019307791A1Use of ferric citrate in the treatment of and the reduction of mortality and morbidity related to adverse cardiac events in chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0827US2019269645A1Use of ferric citrate in the treatment of chronic kidney disease patientsKERYX BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James F. Oliviero, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →